论文部分内容阅读
目的探讨米非司酮治疗围绝经期功能失调性子宫出血的效果。方法将确诊为围绝经期功能失调性子宫出血的患者每晚睡前空腹给予口服米非司酮12.5mg,连服3个月,于治疗前及治疗后分别抽血化验女性激素FSH(卵泡刺激素)、LH(黄体生成素)、P(孕酮)E2(雌二醇),肝肾功能及血常规,同时B超监测子宫内膜厚度。结果33例患者在服药期间均闭经,血清雌激素、孕激素水平下降,FSH、LH变化不明显,无子宫内膜增厚,肝肾功能均正常,血红蛋白均有不同程度的提高,贫血得到改善。结论米非司酮治疗围绝经期功能失调性子宫出血疗效肯定,无肝肾功能损害,是一种安全有效的治疗方法。
Objective To investigate the efficacy of mifepristone in the treatment of dysfunctional uterine bleeding in perimenopausal period. Methods Patients with dysfunctional uterine bleeding during peri-menopausal period were given fasting 12.5 mg of mifepristone orally every night before going to bed, and their clothes were given for 3 months. Blood samples were collected before and after treatment for female hormone FSH (follicle stimulation LH), P (progesterone) E2 (estradiol), liver and kidney function and blood routine, and B-ultrasound monitoring of endometrial thickness. Results All the 33 patients underwent amenorrhoea during menstruation. Serum estrogen and progesterone levels were decreased, but FSH and LH were not significantly changed. There was no endometrial thickening, normal liver and kidney function, hemoglobin increased to some extent and anemia was improved . Conclusion Mifepristone treatment of peri-menopausal dysfunctional uterine bleeding with positive effect, no liver and kidney dysfunction, is a safe and effective treatment.